126 filings
Page 2 of 7
8-K
bfw d62edz794g7m
4 Jan 23
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
8:35am
8-K
wyk ue1jgswfkj
10 Nov 22
Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments
4:06pm
8-K
5ul4z8dkw99rl
27 Oct 22
Other Events
9:06am
8-K
qppfxza c9
13 Sep 22
Dyadic Updates Market On Recent Scientific Achievements
8:30am
8-K
k2qmu i7u14jvs
10 Aug 22
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
4:06pm
8-K
rxf73 y5ip26pmte3z
13 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
ion0v 2pd9t1zsco2nd
12 May 22
Dyadic Reports First Quarter 2022 Financial Results and Highlights Recent Company Developments
4:30pm
8-K
y16749f95
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
hsuhpx6m0 7zkwn9
26 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
vtmms851h qmj0
13 Apr 22
Epygen Biotech Announces Funding from India Government for
4:00pm
8-K
8nw5pvo0
29 Mar 22
Dyadic Reports 2021 Year End Results and Recent Company Progress
4:32pm
8-K
gzal5yc
18 Mar 22
Termination of a Material Definitive Agreement
4:16pm
8-K
u7czru
10 Feb 22
Dyadic and Phibro Animal Health Announce Exclusive License Agreement
12:00am
8-K
n7h8jt3k
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
f5xg37nvs5 287q
2 Dec 21
Other Events
8:30am
8-K
vwa9u
10 Nov 21
Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
4:16pm
8-K
9r1nmhb
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
vtw0xy vev4wac5k1
18 Oct 21
Regulation FD Disclosure
8:30am
8-K
o2cq uxulxy6vhe2xe61
12 Aug 21
Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
4:06pm
8-K
eoqcy7
11 Aug 21
Entry into a Material Definitive Agreement
8:32am